Retrospective observational analysis of ferric pyrophosphate citrate (triferic®) administered via dialysate. Experience at a single facility over 2 years
<p>Background: Ferric pyrophosphate citrate (FPC, Triferic®) is a unique form of iron therapy that is indicated to maintain iron balance and hemoglobin concentration in adult hemodialysis patients. We conducted an analysis of observational data from an independent dialysis facility that has ad...
Saved in:
Main Authors: | Marc Hoffman (Author), Richard Delvalle (Author), Raymond D Pratt (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Nephrology - Peertechz Publications,
2021-06-17.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
by: T. Christopher Bond, et al.
Published: (2012) -
Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients
by: Eun ji Park, et al.
Published: (2019) -
Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
by: Ajay Gupta
Published: (2014) -
Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
by: Xueying Ding, et al.
Published: (2024) -
Pseudogout and Calcium Pyrophosphate Disease
by: Andrew Williamson
Published: (2017)